Caitlin Raymond: Framing Donor Eligibility as Risk Assessment
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, shared on LinkedIn:
“Donor infectious disease eligibility sounds straightforward — until it isn’t. I just published a new post for trainees framing donor eligibility as risk assessment, not a checklist — the way boards expect you to understand it and the way it actually works in practice. In this post I cover:
- Why some pathogens get NAT, others don’t.
- Why some are tested once, others every donation.
- Why donor history still matters in the era of ultra-sensitive testing.
If you work in transfusion medicine, blood banking, pathology, or are studying for boards, this one’s meant to connect the dots between regulations, biology, and real-world decisions.”
Title: Board Prep: Overview of Donor Infectious Disease Eligibility
Author: Caitlin Raymond
Read the full article here.
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda